Clinical Trial Update: A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression [Phase 3]

View source ↗

Summary

Phase 3b multicenter trial of pregabalin in fibromyalgia subjects with comorbid depression completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2014-10-22